Maxim Biomedical today announced the promotion of Chief Operating Officer Jonathan Maa to CEO following a new minority investment from CTM Investments. Rockville, Maryland-based Maxim Biomedical is the rapid diagnostic test developer and manufacturer that makes ClearDetect COVID-19 Antigen Home Tests and products for HIV testing. Jonathan Maa’s father, Maxim Biomedical co-founder and former CEO […]
Maxim Biomedical
FDA extends shelf life of some popular COVID tests
The FDA announced today that certain COVID-19 diagnostic tests under emergency use authorization now have a longer shelf life. Diagnostics made by Abbott, Maxim Biomedical and iHealth Labs all received extensions for their expiration dates. The Abbott BinaxNow COVID-19 antigen self-tests now have a shelf life of 22 months. Previously, the popular test had a […]
NIH to boost COVID-19 testing capabilities
The National Institutes of Health announced a $129.3 million plan to support scaling and manufacturing for COVID-19 tests. As part of its Rapid Acceleration of Diagnostics (RADx) initiative, NIH is awarding contracts to nine companies for their technologies that include portable point-of-care tests for immediate results and high-throughput laboratories that can produce results in 24 […]
